Study of COYA 302 for the Treatment of ALS
Trial details
- Registry ID
- NCT07161999
- Drugs studied
- COYA 302
TrialRedline tracks 1 clinical trial sponsored by Coya Therapeutics: 1 Phase 2 / 3.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of COYA 302 for the Treatment of ALSNCT07161999 | COYA 302 | Active not recruiting | 2027-04Estimated |
Names as written in the registry records.
NCT07161999 · Coya Therapeutics
Before: Jan 2027. After: Apr 2027.
Before: Recruiting. After: Active not recruiting.
NCT07161999 · Coya Therapeutics
Before: PHASE2. After: PHASE2, PHASE3.